Senate bill S4333-117

Health, Education, Labor, and Pensions Committee

CLEAR Act

• Last activity on May 26, 2022

• Introduced May 26, 2022

• By Sen. Smith, Tina [D-MN]

Support this bill

Main Subject: Health

Consistent Legal Evaluation And Regulation of Medical Products Act or the CLEAR Act

This bill requires the Food and Drug Administration to regulate contrast agents for medical imaging devices, radioactive drugs, over-the-counter monograph drugs, and ophthalmic drug articles (i.e., eye droppers) as drugs rather than medical devices.

Senate Actions

IntroReferral
May. 26 2022	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Library of Congress Actions

IntroReferral
May. 26 2022	Introduced in Senate

Senate bill S4333-117

CLEAR Act

Promote the cause!

Or use this QR code